Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Mangoceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 1 | 5 | +4 |
| Shares | 4.67K | 91.0K | +86.3K (+1,849.7%) |
| Value | $5.32K | $166.4K | +$161.1K (+3,029.8%) |
New holders (4)
Institutions that held Mangoceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Colonial River Wealth Management, LLC | 36,100 | $66.1K | 0.04% |
| Two Sigma Investments, LP | 27,103 | $49.6K | 0.00% |
| Independent Advisor Alliance | 26,000 | $47.6K | 0.00% |
| Private Trust Co NA | 1,500 | $2.75K | 0.00% |
Sold out (0)
Institutions that held Mangoceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
None.